Ubs Group Ag M Dx Health Sa Transaction History

Ubs Group Ag

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$3.07 - $4.2 $307 - $420	100 New	100 $0
Q4 2022 Feb 08, 2023	BUY	$6.2 - $8.36 $2,796 - $3,770	451 Added 20.57%	2,644 $17,000
Q3 2022 Nov 10, 2022	BUY	$6.1 - $8.84 $12 - $17	2 Added 0.09%	2,193 $15,000
Q2 2022 Aug 10, 2022	BUY	$6.65 - $9.33 $12,541 - $17,596	1,886 Added 618.36%	2,191 $18,000
Q1 2022 May 16, 2022	BUY	$7.69 - $10.27 $2,345 - $3,132	305 New	305 $3,000

9.5K

Ticker MDXH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,288,100
Market Cap $34.7M
Description
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which prov...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.